Literature DB >> 17203776

The PTHrP/PTH.1-R bioregulation system in cardiac hypertrophy: possible therapeutic implications.

Antonis Halapas1, Evanthia Diamanti-Kandarakis, Demetrios Kremastinos, Michael Koutsilieris.   

Abstract

Myocardial hypertrophy is associated with specific histological changes, which are representative of the cardiomyocytes cellular response to overload. Evidently, transcriptional modulation of specific genes is implicated in myocardial hypertrophy. Recently, the parathyroid hormone-related protein (PTHrP)/PTH-1 receptor (PTH-1.R) bioregulation system was shown to participate in specific regulatory processes of the cardiomyocyte function and proliferation, which can be related to cardiac hypertrophy and heart failure. We review the literature on the pathophysiology of cardiac hypertrophy vis-a-vis the role of PTHrP/PTH-1.R system as a good therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17203776

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  3 in total

1.  Original Research: Atorvastatin prevents rat cardiomyocyte hypertrophy induced by parathyroid hormone 1-34 associated with the Ras-ERK signaling.

Authors:  Xiaogang Liu; Chunbo Zou; Chengyuan Yu; Rujuan Xie; Manshu Sui; Suhong Mu; Li Li; Shilei Zhao
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-10

2.  Correlation between Left Ventricular Mass Index and Calcium Metabolism in Patients with Essential Hypertension.

Authors:  Ayşen Helvacı; Besime Copur; Mine Adaş
Journal:  Balkan Med J       Date:  2013-03-01       Impact factor: 2.021

3.  The Association between Changes in Low Parathyroid Hormone Levels and Cardiac Function Decline in Maintenance Hemodialysis Patients: A Prospective Observational Study.

Authors:  Xiao-Han Lu; Meng-Si Li; Yao-Yao Li; Yan-Dan Zheng; Xiao-Yan Wu; Ping Gao
Journal:  Med Princ Pract       Date:  2021-07-30       Impact factor: 1.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.